In this special episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Emily Reams to break down the most practice-changing takeaways from SHM Converge 2026.
No fluff — just what you can start doing on rounds tomorrow.
Topics include:
Flu shots in heart failure — real mortality benefit
Stopping aspirin in patients on DOACs
Anticoagulation in AFib despite fall risk
Naltrexone for alcohol use disorder — start inpatient
Phenobarbital for withdrawal — coming soon
Metformin in the hospital — dogma challenged
Transfusion thresholds in MI
“Things We Do for No Reason” highlights
Practical take-homes and what to actually change this week.
Practice-Changing Highlights
💉 Flu shots in heart failure NNT ≈ 17 for death/readmission → Vaccinate before discharge during flu season
💊 Stop aspirin with DOACs ↑ bleeding and mortality without benefit → Stop aspirin ~6–12 months post-stent (most patients)
🧠 AFib + fall risk Benefit >> risk (would need >450 falls/year to offset) → Don’t withhold anticoagulation for falls alone
🍺 Alcohol use disorder
Naltrexone: start before discharge → ↓ cravings, ↓ readmissions
Phenobarbital: increasing use, likely future standard
💊 Metformin inpatient May be safe in select patients → Consider if GFR ≥30 and no lactic acidosis
🩸 Transfusion in MI Target Hgb ~10 may reduce mortality → Evolving — keep on radar
💊 Anticoagulation updates
Apixaban preferred over rivaroxaban
Reduce dose after 3–6 months for VTE → Reassess dosing routinely
Podden och tillhörande omslagsbild på den här sidan tillhör
Mason Turner, MD. Innehållet i podden är skapat av Mason Turner, MD och inte av,
eller tillsammans med, Poddtoppen.